(Q37700546)

22 August 2017

1 reference

title

The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro (English)

1 reference

22 August 2017

author

Manuel Cuenca-Estrella

series ordinal

1

object named as

Manuel Cuenca-Estrella

1 reference

22 August 2017

author name string

Juan Luis Rodriguez-Tudela

series ordinal

2

1 reference

22 August 2017

publication date

1 March 2010

1 reference

Expert Review of Anti-infective Therapy

22 August 2017

published in

1 reference

22 August 2017

volume

8

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

267-276

1 reference

Has antifungal susceptibility testing come of age?

22 August 2017

cites work

1 reference

Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of candida species

21 January 2018

1 reference

International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole

21 January 2018

1 reference

Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2)

21 January 2018

1 reference

Trends in antifungal susceptibility testing using CLSI reference and commercial methods

21 January 2018

1 reference

Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques

21 January 2018

1 reference

Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts

21 January 2018

1 reference

Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species

21 January 2018

1 reference

Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods

21 January 2018

1 reference

Vulvovaginal candidiasis in a Flemish patient population

21 January 2018

1 reference

Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp.

21 January 2018

1 reference

Comparison of Neo-Sensitabs tablet diffusion assay with CLSI broth microdilution M38-A and disk diffusion methods for testing susceptibility of filamentous fungi with amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole

21 January 2018

1 reference

Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin

21 January 2018

1 reference

Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species

21 January 2018

1 reference

Detection of resistance to amphotericin B in Candida isolates by using Iso-Sensitest broth

21 January 2018

1 reference

Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing

21 January 2018

1 reference

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

21 January 2018

1 reference

Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.

21 January 2018

1 reference

Clinical pharmacokinetics of fluconazole

21 January 2018

1 reference

Use of drug effect interaction modeling with Monte Carlo simulation to examine the impact of dosing interval on the projected antiviral activity of the combination of abacavir and amprenavir

21 January 2018

1 reference

Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint

21 January 2018

1 reference

Use of Monte Carlo simulations to select therapeutic doses and provisional breakpoints of BAL9141.

21 January 2018

1 reference

A retrospective analysis using Monte Carlo simulation to evaluate recommended ceftazidime dosing regimens in healthy volunteers, patients with cystic fibrosis, and patients in the intensive care unit

21 January 2018

1 reference

In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003.

21 January 2018

1 reference

Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.

21 January 2018

1 reference

Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.

21 January 2018

1 reference

Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans

21 January 2018

1 reference

Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.

21 January 2018

1 reference

Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility

21 January 2018

1 reference

Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland

21 January 2018

1 reference

Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital

21 January 2018

1 reference

Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study

21 January 2018

1 reference

Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program

21 January 2018

1 reference

The epidemiology of candidemia in two United States cities: results of a population-based active surveillance

21 January 2018

1 reference

Invasive Candida species infections: a 5 year population-based assessment

21 January 2018

1 reference

One year prospective survey of Candida bloodstream infections in Scotland.

21 January 2018

1 reference

Candidemia in Finland, 1995-1999.

21 January 2018

1 reference

Candidemia in Norway (1991 to 2003): results from a nationwide study

21 January 2018

1 reference

National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin

21 January 2018

1 reference

Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain.

21 January 2018

1 reference

Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study.

21 January 2018

1 reference

Candidaemia in Europe: epidemiology and resistance

21 January 2018

1 reference

Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry

21 January 2018

1 reference

Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers

21 January 2018

1 reference

Data mining validation of fluconazole breakpoints established by the European Committee on Antimicrobial Susceptibility Testing

21 January 2018

1 reference

Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia

21 January 2018

1 reference

Epidemiology of invasive candidiasis: a persistent public health problem

21 January 2018

1 reference

In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.

21 January 2018

1 reference

Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints

21 January 2018

1 reference

Antifungal drug resistance: do molecular methods provide a way forward?

21 January 2018

1 reference

Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003

21 January 2018

1 reference

Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans

21 January 2018

1 reference

Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002.

21 January 2018

1 reference

In vitro susceptibility of Cryptococcus gattii clinical isolates.

21 January 2018

1 reference

Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review

21 January 2018

1 reference

Saccharomyces cerevisiae fungemia: an emerging infectious disease

21 January 2018

1 reference

Susceptibility patterns and molecular identification of Trichosporon species

21 January 2018

1 reference

Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.

21 January 2018

1 reference

Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism

21 January 2018

1 reference

Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience

21 January 2018

1 reference

Incidence of zygomycosis in transplant recipients

21 January 2018

1 reference

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

21 January 2018

1 reference

Zygomycosis: an emerging fungal infection with new options for management

21 January 2018

1 reference

Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERI.10.2

1 reference

22 August 2017

1 reference